Deadline: October 14

Charité study demonstrates efficacy of CD19 CAR T cells in first patients

CEPI backs Minapharm's Bundibugyo ebolavirus vaccine candidate, based on ProBioGen's proprietary MVA-CR19 platform

A seven protein ​“signature” in blood can indicate successful treatment for vasculitis. The Mertins, Forslund and Kettritz labs report in ​“Nature Communications” how they used proteomics and AI to identify biomarkers, which could enable more…

ESA astronaut Sophie Adenot is the first study participant

An EU-funded research project coordinated by the Berlin Institute of Health at Charité (BIH) has uncovered how the pancreas develops, adapts, and changes in disease. The study has now been published in Cell Metabolism.

The German Stem Cell Network is honoring Maike Sander with a Hilde Mangold Award. The network recognized Sander for her scientific excellence, outstanding scientific leadership, and impact as a role model for women in research.

Researchers from Charité – Universitätsmedizin Berlin have gained new insights into the long-term effects of NMDA receptor encephalitis. In this section, first author Dr. Stephan Krohn and senior author Prof. Carsten Finke answer questions about…

- Milestone marks Kupando’s evolution from a research-focused organization to a clinical-stage biopharmaceutical company

- Phase 1 trial evaluates KUP101, a differentiated dual Toll-Like Receptor (TLR) 4/7 agonist designed to harness innate immunity…

- Combining complementary strengths

- A broader range of products for pharmacies from a single source 

- A common foundation for reliable supply and growth in Germany and Europe